AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7889637
Drug: Nifedipine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (30 mg sustained release daily)
Trial: 7889637
Drug: Verapamil (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (240 mg sustained release daily)
Trial: 209485
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg estradiol valerate (single oral dose)
Trial: 29642743
Drug: Weekly problem‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly problem‐based sessions led by psychologists over 3 months
Trial: 24115188
Drug: Fluoxetine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (up to 40 mg/day) plus lovastatin (30 mg/day)
Trial: 10955034
Drug: Therapy focusing
RxNorm normalized name: ficusin
DrugBank: Psoralen (DB18665)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy focusing on reversing the underlying disorder and providing supportive treatment
Trial: 9244023
Drug: Paracetamol 325
RxNorm normalized name: Paracetamol 325 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 325 mg/dextropropoxyphene hydrochloride 32.5 mg
Trial: 9244023
Drug: Paracetamol 500
RxNorm normalized name: Paracetamol 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 500 mg/codeine phosphate 30 mg
Trial: 8143995
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with folinic acid 200 mg/m2 plus 5-fluorouracil 400 mg/m2, intravenously, on days 1-5 every 4 weeks for 12 cycles
Trial: 29231320
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (carbamazepine)
Trial: 23134408
Drug: TAC with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAC with 6 months steroids withdrawal (6M SW)
Trial: 23134408
Drug: TAC with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAC with 3 months steroids withdrawal (3M SW)
Trial: 23134408
Drug: TAC with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAC with 14 days steroids withdrawal (14d SW)
Trial: 23134408
Drug: TAC with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAC with basiliximab induction and steroids avoidance (Bas SA)
Trial: 15199653
Drug: Medication and
RxNorm normalized name: CVS Health Medication and Topical Refill Pouch KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication and psychoeducation
Trial: 15199653
Drug: Medication without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medication without psychoeducation
Trial: 11300428
Drug: Nitroglycerin (NTG)
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (NTG) 400 microg sublingual
Trial: 9378379
Drug: Atropine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (15 micrograms/kg intravenous bolus and 4 micrograms/kg/h maintenance dose)
Trial: 3535012
Drug: Cisapride 8
RxNorm normalized name: Cisapride
DrugBank: Cisapride (DB00604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisapride 8 mg intravenously
Trial: 3535012
Drug: Cisapride 20
RxNorm normalized name: cisapride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 20 mg intravenously
Trial: 3535012
Drug: Cisapride 1
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 1 mg atropine pretreatment
Trial: 3535012
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg three times daily (1-week treatment)
Trial: 28921241
Drug: DHEA 6.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA 6.5 mg
Trial: 28921241
Drug: DHEA 3.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA 3.25 mg
Trial: 28921241
Drug: DHEA 6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA 6.25 mg
Trial: 25013997
Drug: NNC0195‐0092 (0.01‐0.32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNC0195‐0092 (0.01‐0.32 mg/kg) single dose
Trial: 25013997
Drug: NNC0195‐0092 (0.02‐0.24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNC0195‐0092 (0.02‐0.24 mg/kg) once-weekly doses for 4 weeks
Trial: 18474811
Drug: Anakinra (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (150 mg s.c.)
Trial: 14600860
Drug: Bupivacaine 0.125%
RxNorm normalized name: BUPIVACAINE 0.125%/NS INJ 250ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.125% with sufentanil 0.5 microg/ml
Trial: 8869862
Drug: Recombinant hirudin
RxNorm normalized name: hirudin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hirudin (group 1: 0.3 mg.kg‐1 i.v. bolus, 0.12 mg.kg‐1.h‐1 i.v. infusion)
Trial: 8869862
Drug: Recombinant hirudin
RxNorm normalized name: hirudin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hirudin (group 2: 0.5 mg.kg‐1 i.v. bolus, 0.24 mg.kg‐1.h‐1 i.v. infusion)
Trial: 8869862
Drug: Heparin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (150 IU.kg‐1 i.v. bolus, 20 IU.kg‐1.h‐1 i.v. infusion)
Trial: 26471380
Drug: BRV 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BRV 100 mg/day
Trial: 21386714
Drug: Medication (control)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (control)
Trial: 16979857
Drug: Clustered nursing
RxNorm normalized name: cluster fig extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clustered nursing care (CC)
Trial: 14688156
Drug: 50 IU
RxNorm normalized name: Pegaspargase 750 IU/1 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 IU of recombinant FSH daily and GnRH antagonist Ganirelix 0.25 mg per day
Trial: 14688156
Drug: 50 IU
RxNorm normalized name: Pegaspargase 750 IU/1 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 IU of recombinant FSH on alternate days and GnRH antagonist Ganirelix 0.25 mg per day
Trial: 18206738
Drug: Defibrillator therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Defibrillator therapy
Trial: 9626173
Drug: Medications alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medications alone (Control)
Trial: 2835195
Drug: Enalapril maleate
RxNorm normalized name: Enalapril Maleate
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril maleate (10 mg)
Trial: 28266949
Drug: venlafaxine 75 mg + hypnosis
RxNorm normalized name: venlafaxine 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: venlafaxine 75 mg + hypnosis (VH)
Trial: 28266949
Drug: venlafaxine 75 mg + sham
RxNorm normalized name: venlafaxine 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: venlafaxine 75 mg + sham hypnosis (VSH)
Trial: 28266949
Drug: placebo pill + hypnosis
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo pill + hypnosis (PH)
Trial: 28266949
Drug: placebo pill + sham
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo pill + sham hypnosis (PSH)
Trial: 26245216
Drug: Personalized treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized treatment defined by IFX and anti‐IFX antibodies (n = 33)
Trial: 16804124
Drug: Free amino
RxNorm normalized name: FREE AMINO ACID DIET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free amino acid solutions
Trial: 16804124
Drug: Standardized oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized oral meal (healthy volunteers)
Trial: 14674505
Drug: 24% EDTA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24% EDTA gel followed by 5% NaOCl for 2 minutes
Trial: 14674505
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no etching agent and/or NaOCl solution)
Trial: 11009265
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus cilostazol (group II, n = 208, 254 lesions) for 6 months
Trial: 11009265
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus ticlopidine (group I, n = 201, 240 lesions) for 1 month
Trial: 11009265
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus cilostazol (group II) in diabetic patients
Trial: 11009265
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus ticlopidine (group I) in diabetic patients
Trial: 11009265
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus cilostazol (group II)
Trial: 11009265
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus ticlopidine (group I)
Trial: 1581367
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment control group
Trial: 6146180
Drug: Diphenhydramine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine (150 mg)
Trial: 25966781
Drug: OZ439 plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OZ439 plus PQP (800 mg OZ439 with 960 mg PQP)
Trial: 25966781
Drug: OZ439 plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OZ439 plus PQP (800 mg OZ439 with 1440 mg PQP)
Trial: 17236636
Drug: Propofol target
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol target controlled infusion (TCI) with noxious stimulus (hand immersion in cold water at 2-4 degrees C)
Trial: 17236636
Drug: Remifentanil TCI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil TCI infusion added to propofol TCI anesthesia
Trial: 12771852
Drug: Daflon 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daflon 500 mg (2 tablets/day for 6 months)
Trial: 12771852
Drug: Compression therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compression therapy alone (Control group)
Trial: 8812724
Drug: Chronic sodium
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic sodium benzoate (SB) therapy
Trial: 4084669
Drug: Allopurinol tablets
RxNorm normalized name: Allopurinol Tablets
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol tablets 100 mg, DAK
Trial: 4084669
Drug: Apurin tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apurin tablets 100 mg, Gea
Trial: 30205427
Drug: Carnosine 2
RxNorm normalized name: ASCORBIC ACID 200 mg / Vitamin D 20 ug / FOLIC ACID 1667 ug / CYANOCOBALAMIN 6 ug / CALCIUM CITRATE 40 mg / IRON PROTEIN SUCCINYLATE 3.6 mg / MAGNESIUM GLYCINATE 8.5 mg / MAGNESIUM OXIDE 60.3 mg / ZINC 8 mg / POLAPREZINC 37.5 mg / CARNOSINE 28 mg ORAL CAPSULE [Remedient]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carnosine 2 g
Trial: 27049809
Drug: 3.0% diquafosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0% diquafosol tetrasodium ophthalmic solution
Trial: 24976433
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (200 μg as selenomethionine)
Trial: 20880348
Drug: Sodium tungstate
RxNorm normalized name: Sodium Tungstate Dihydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium tungstate (100 mg bid)
Trial: 18024853
Drug: GW501516 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GW501516 (10 mg o.d.)
Trial: 16005162
Drug: Morphine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (50 mg and 25 mg)
Trial: 1942422
Drug: Zidovudine 1200
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine 1200 mg daily (protocol 016)
Trial: 1942422
Drug: Zidovudine 500
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine 500 mg daily (protocol 019)
Trial: 1942422
Drug: Zidovudine 1500
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine 1500 mg daily (protocol 019)
Trial: 1942422
Drug: Zidovudine (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (any dosage)
Trial: 6791868
Drug: Oral mannitol
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral mannitol alone
Trial: 6791868
Drug: Oral mannitol
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral mannitol with colonic washout
Trial: 31711752
Drug: ABI-H0731 100
RxNorm normalized name: PICEA ABIES WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABI-H0731 100 mg
Trial: 31711752
Drug: ABI-H0731 200
RxNorm normalized name: PICEA ABIES WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABI-H0731 200 mg
Trial: 31711752
Drug: ABI-H0731 300
RxNorm normalized name: PICEA ABIES WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABI-H0731 300 mg
Trial: 31711752
Drug: ABI-H0731 (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABI-H0731 (various doses)
Trial: 30968678
Drug: Lertal +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lertal + standard treatment
Trial: 30968678
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + standard treatment
Trial: 28660990
Drug: Occlusal splint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occlusal splint therapy (Michigan splint) for 30 days
Trial: 19515290
Drug: Daily alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily alcohol use
Trial: 23303903
Drug: Ginger (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger (2.0 g daily for 28 days)
Trial: 16540287
Drug: Ampiroxicam 27
RxNorm normalized name: Piroxicam
DrugBank: Piroxicam (DB00554)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ampiroxicam 27 mg
Trial: 7742745
Drug: rhu EPO
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rhu EPO (300 units per kg/day given thrice weekly by intravenous injection)
Trial: 2285274
Drug: Rimantadine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimantadine (100 mg daily)
Trial: 7433474
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg doxycycline daily for 10 days
Trial: 7433474
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg doxycycline on the first day and 100 mg on subsequent days for 8 days
Trial: 30707360
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement cycle (HRC)
Trial: 30208454
Drug: Piperacillin-tazobactam, 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin-tazobactam, 4.5 g, every 6 hours (n=188 participants)
Trial: 30208454
Drug: Meropenem, 1
RxNorm normalized name: Meropenem, 1000 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem, 1 g, every 8 hours (n=191 participants)
Trial: 22575072
Drug: Low ED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low ED (consume ≥10 foods ≤1.0 kcal/g dietary ED and ≤2 foods ≥3.0 kcal/g dietary ED per day)
Trial: 17942381
Drug: Calcium therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium therapy
Trial: 16291885
Drug: Modafinil (200-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (200-400 mg/day)
Trial: 15248189
Drug: Onofin-K (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onofin-K (200 mg)
Trial: 15248189
Drug: Nizoral (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizoral (200 mg)
Trial: 11317474
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg fluvastatin twice per day over a 3-month period (n = 14)
Trial: 9393270
Drug: BCAAs (Aminoleban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAAs (Aminoleban EN) 100 g per day for 1 year
Trial: 3583472
Drug: Euphylong administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euphylong administered after a hot evening meal
Trial: 3583472
Drug: Euphylong administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euphylong administered before a cold evening meal
Trial: 27519921
Drug: NIV combined
RxNorm normalized name: ReddyPort NIV Maintenance Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIV combined with HFNC (pressure support=10, PEEP=5, FiO2=100% + flow=60 L/min, FiO2=100%)
Trial: 22502790
Drug: TAM 20
RxNorm normalized name: sulbactam 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAM 20 mg daily orally (arm A)
Trial: 22502790
Drug: TAM 10
RxNorm normalized name: sulbactam 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAM 10 mg daily starting simultaneously with bicalutamide (arm B)
Trial: 17869051
Drug: Two-session brief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-session brief intervention (motivational enhancement therapy)
Trial: 17869051
Drug: 3-month delayed-treatment
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-month delayed-treatment control condition
Trial: 10097506
Drug: Atarax (hydroxyzine)
RxNorm normalized name: hydroxyzine hydrochloride Oral Solution [Atarax]
DrugBank: Hydroxyzine (DB00557)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atarax (hydroxyzine) 50 mg daily for 28 days
Trial: 1875413
Drug: Total doses
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total doses D1, D2, D3, and D4 differing by increments of 4.8 Gy, with all patients receiving two fractions of 1.2 Gy each daily 5 days a week.
Trial: 1875413
Drug: Regimen D3
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen D3 (highest dose)
Trial: 29122186
Drug: IMU-based inclinometer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMU-based inclinometer solutions
Trial: 26888208
Drug: Bright white-light
RxNorm normalized name: Light White Mineral Oil
DrugBank: Light mineral oil (DB11579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright white-light treatment (BLT, broad-wavelength light without UV 10,000 lux, irradiance 31.7 Watt/m(2))
Trial: 24419823
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) injection (3 cc)
Trial: 24419823
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection (40 mg DepoMedrol)
Trial: 20958144
Drug: Sidestream(®) nebulizer
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sidestream(®) nebulizer coupled to a 110‐mL corrugated piece of tubing
Trial: 17211605
Drug: Routine intravenous
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine intravenous prophylaxis of isoxazolyl-penicillin
Trial: 8018462
Drug: (S)-flurbiprofen 50
RxNorm normalized name: flurbiprofen 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (S)-flurbiprofen 50 mg
Trial: 8018462
Drug: (R)-flurbiprofen 50
RxNorm normalized name: flurbiprofen 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (R)-flurbiprofen 50 mg
Trial: 8018462
Drug: (R)-flurbiprofen 100
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: (R)-flurbiprofen 100 mg
Trial: 3050904
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg inhaled gallopamil
Trial: 3050904
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg inhaled gallopamil
Trial: 25520249
Drug: Sibutramine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine treatment with diet and exercise
Trial: 24460649
Drug: V-G haplotype
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: V-G haplotype (rs1800206, rs4253778)
Trial: 15468574
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of albendazole (400 mg)
Trial: 15468574
Drug: Nitazoxanide (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitazoxanide (1.2 g single dose)
Trial: 15468574
Drug: Nitazoxanide (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitazoxanide (15 mg/kg/day for three days)
Trial: 15468574
Drug: Nitazoxanide (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitazoxanide (single dose)
Trial: 2100983
Drug: Parenteral cefoxitin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral cefoxitin (given in three divided doses)
Trial: 2100983
Drug: No parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No parenteral antibiotics (control group)
Trial: 150816
Drug: Dry patch
RxNorm normalized name: LIDOCAINE 40 mg TOPICAL PATCH [Pain Relief 4% Lidocaine Dry Patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dry patch test (control)
Trial: 31421668
Drug: Physiotherapy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy combined with corticosteroid injection